TXMD THERAPEUTICSMD INC Management Changes 8-K Filing 2024 - Annual Meeting Results TherapeuticsMD, Inc. held its 2024 Annual Meeting where stockholders elected four directors, approved executive compensation, and ratified the appointment of an independent auditor, with a total of 11,532,432 shares outstanding and 6,832,199 shares represented at the meeting.Get access to all SEC 8-K filings of the THERAPEUTICSMD INC